2010.

• Dec.10.2010

  Results of Phase Ⅱb Study of Carfizomib were Presented at the 52nd American Society of Hematology Annual Meeting(69 KB)

• Nov.11.2010

  Approval Received for Orally Disintegrating Tablet of imidafenacin (INN), a Drug for Overactive Bladder(17 KB)

• Nov.04.2010

  Announcement on Acquisition of the Company's Own Shares(59 KB)

• Oct.28.2010

  Ono and MSD Submit Additional Indication Application for Sitagliptin Combination Therapy with Insulin(92 KB)

• Sep.24.2010

  Application Filed in Japan for an Intravenous Antiemetic Selective Neurokinin-1 (NK1) Receptor Antagonist(17 KB)

• Sep.10.2010

  Application for RECALBON® Tablets 50mg/ Bonoteo® Tablets 50mg,A Monthly Oral Osteoporosis Treatment in Japan(16 KB)

• Sep.08.2010

  Ono Announces Carfilzomib Development and Commercialization Agreement with Onyx Pharmaceuticals for Japan(81 KB)

• Sep.08.2010

  Revisions of Consolidated Financial Forecasts(45 KB)

• Sep.01.2010

  Ono Enters into License Agreement with Concordia for New Therapeutic Agent for Pancreatic Cancer(16 KB)

• Jul.29.2010

  NDA Submission in Japan for Onoact® 50 for Injection, Short-Acting Selective β1 Blocker for Improvement of Image Quality of Coronary Arteries for Coronary CT Angiography(46 KB)

• Jun.24.2010

  Ono and Banyu File Additional Indication Application for Type-2 Diabetes Drug Sitagliptin - Combination Therapy with α-Glucosidase Inhibitors -(341 KB)

• Mar.23.2010

  Ono Enters into Drug Discovery Agreement on Bioactive Lipid with BioSeek(16 KB)

• Mar.01.2010

  NDA Submission in Japan for rivastigmine patch,the first transdermal patch therapy to treat Alzheimer's disease(11 KB)

• Feb.04.2010

  Ono to Support Relief Efforts for Haitian Earthquake Victims(10 KB)

• Jan.07.2010

  Application filed for Orally Disintegrating Tablet of imidafenacin (INN),a Drug for Overactive Bladder(12 KB)